Skip to content

Research use only. Supplied for in vitro laboratory research. Not for human or veterinary use. Conditions

CJC-1295 DAC 5MG research peptide vial

Move to inspect

Shipped lyophilised
Free shipping over $300
Calculator supported

Albumin-Binding GHRH Analogue

CJC-1295 DAC

5MG per vial

CJC-1295 DAC is a synthetic analogue of growth hormone-releasing hormone built on the GHRH(1-29) scaffold, carrying four substitutions — D-Ala2, Gln8, Ala15 and Leu27 — plus a thirtieth residue, lysine, bearing an N-epsilon-3-maleimidopropionamide group known as the Drug Affinity Complex. It agonises the GHRH receptor, a class B GPCR on anterior pituitary somatotrophs, coupling through Gs to adenylyl cyclase, raising intracellular cAMP and triggering calcium-dependent exocytosis of growth hormone secretory granules. The maleimide reacts with the free thiol of Cys34 on serum albumin to form a covalent conjugate, and that bioconjugation is what distinguishes this form from CJC-1295 without DAC, otherwise known as modified GRF(1-29).

StockLive

In stock

Available to ship today

Pricing on request

Prices are still being set. Add what you need to your cart and request a quote from there — we will come back with current pricing and availability, usually within one business day.

Cart

Research use only. Supplied for in vitro laboratory research. Not a drug, supplement, cosmetic or medical device, not approved by the TGA, and not for administration to humans or animals. See our research use conditions.

Compound signature

From confirmed structure

3647g/mol

Molar mass

258atoms

Heavy atoms

Atomic composition

C165H269N47O46

  • C165
  • H269
  • N47
  • O46

Characterised targets

  • GHRHR

Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(epsilon-3-maleimidopropionamide)-NH2

Research applications

Each substitution addresses a specific liability of native GHRH: D-Ala at position 2 blocks dipeptidyl peptidase-4 cleavage, Gln8 removes an asparagine deamidation site, Leu27 removes a methionine oxidation site, and Ala15 is reported to have been introduced to raise receptor potency. Published pharmacokinetic characterisation reports a terminal half-life in the region of six to eight days, reflecting the circulating albumin-bound reservoir, against the minutes-scale clearance of unmodified GHRH. That difference in residence time is why the compound recurs as a comparator in work distinguishing continuous from pulsatile stimulation of the somatotroph axis, where growth hormone and IGF-I concentrations are tracked over a timescale of days rather than minutes and pulse amplitude and trough concentrations are the readouts of interest.

Formulation and handling

Supplied as a lyophilised powder. The maleimide is a chemically reactive handle rather than an inert tag: reconstitution in buffers containing free thiols such as DTT, beta-mercaptoethanol or cysteine will consume it, and maleimides hydrolyse to the unreactive maleamic acid under alkaline conditions, so a near-neutral to slightly acidic solvent preserves albumin-conjugating capacity. Treat it as a thiol-reactive reagent rather than a plain peptide.

Intended use

CJC-1295 DAC is supplied exclusively for in vitro and non-clinical scientific research. It is not approved for human or animal therapeutic, diagnostic or medicinal use. All handling and experimentation must be carried out by trained personnel in an appropriately controlled laboratory.

Specification

Presentation
Vial
Labelled strength
5MG
Molecular formula
C165H269N47O46
Molar mass
3647.2 g/mol
CAS number
863288-34-0
Molecular targets
GHRHR
Appearance
Lyophilised powder
Storage
2–8 °C sealed, −20 °C long term

Values describe the compound as supplied. Analytical figures for the material in your vial are on that lot’s certificate, not here.

Certificates of analysis

None published yet

Every lot is tested by an independent laboratory and carries its own certificate. Match the lot number printed on your vial to the certificate — a certificate for a different lot tells you nothing about yours.

  • Slot 1

    Awaiting upload

    The certificate for the next tested lot will appear here. Until then, ask us for the one matching your vial.

  • Slot 2

    Awaiting upload

    The certificate for the next tested lot will appear here. Until then, ask us for the one matching your vial.

  • Slot 3

    Awaiting upload

    The certificate for the next tested lot will appear here. Until then, ask us for the one matching your vial.

Also in the range

Related compounds